Breaking News

San Diego Cell Therapy CDMO Acquired by Healthcare-Focused Private Equity Firm

Company also announces new name and leadership slate.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Performance Cell Manufacturing (PCM), a contract development and manufacturing organization (CDMO) with more than 15 years of experience in manufacturing cell therapies, has been acquired by Great Point Partners (GPP), a Greenwich, CT-based private investment firm focused on the healthcare industry. As part of the deal, the company also announced that it will operate under a new name: Cellipont Bioservices.   This is the latest in a series of CDMO investments by Great Point Partners. The firm ha...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters